Helicobacter pylori: gastric cancer and beyond, Nature Reviews Cancer, vol.10, issue.6, pp.403-417, 2010. ,
,
,
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis, Gastroenterology, vol.153, issue.2, pp.420-429, 2017. ,
Diagnosis and Risk Factors of Helicobacter pylori Infection, Helicobacter pylori in Human Diseases: Advances in Microbiology, vol.11, pp.17-33, 2019. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02868133
Review: Epidemiology of Helicobacter pylori infection, Helicobacter, vol.24, p.12635, 2019. ,
, Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report, vol.66, pp.6-30, 2017.
faculty members of Kyoto Global Consensus, Kyoto global consensus report on Helicobacter pylori gastritis, Gut, vol.64, issue.9, pp.1353-67, 2015. ,
,
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial, The Lancet, vol.372, issue.9636, pp.392-397, 2008. ,
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention, Gut, vol.62, issue.5, pp.676-82, 2013. ,
Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials, BMJ, vol.348, p.3174, 2014. ,
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China. A Randomized Controlled Trial, The Journal of the American Medical Association, vol.291, pp.187-194, 2004. ,
Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study, Bmc Infect Dis, vol.19, 2019. ,
Treatment of Helicobacter pylori Infection, Helicobacter, vol.20, pp.54-61, 2015. ,
,
The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use, Digestive and Liver Disease, vol.48, issue.4, pp.385-390, 2016. ,
Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection, Aliment Pharm Ther, vol.47, issue.7, pp.868-876, 2018. ,
The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection, Expert Review Anti-Infective Therapy, vol.12, issue.8, pp.981-92, 2014. ,
Treatment of Helicobacter pylori infection: Current and future insights, World Journal of Clinical Cases, vol.4, issue.1, pp.5-19, 2016. ,
Antibiotic treatment for Helicobacter pylori : Is the end coming?, World Journal of Gastrointestinal Pharmacology and Therapeutics, vol.6, issue.4, pp.183-198, 2015. ,
Chitosan-albumin based core shell-corona nano-antimicrobials to eradicate resistant gastric pathogen, International Journal of Biological Macromolecules, vol.138, pp.1006-1018, 2019. ,
Induction of Mincle by Helicobacter pylori and consequent anti-inflammatory signaling denote a bacterial survival strategy, Scientific Reports, vol.5, p.15049, 2015. ,
Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways, Biochimica et Biophysica Acta (BBA) -Molecular Basis of Disease, vol.1852, issue.9, pp.1928-1967, 2015. ,
Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis, Biomedical Journal, vol.39, issue.1, pp.14-23, 2016. ,
Pathobiology of Helicobacter pylori-Induced Gastric Cancer, Gastroenterology, vol.150, issue.1, pp.64-78, 2016. ,
Low-Molecular-Weight Dextran Sulfate Nanocapsules Inhibit the Adhesion of Helicobacter pylori to Gastric Cells, ACS Applied Bio Materials, vol.2, issue.11, pp.4777-4789, 2019. ,
Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori, Journal of Drug Targeting, vol.17, issue.3, pp.225-259, 2009. ,
Preparation and evaluation of amoxicillin loaded dual molecularly imprinted nanoparticles for anti-Helicobacter pylori therapy, International Journal of Pharmaceutics, vol.496, issue.2, pp.1006-1020, 2015. ,
Floating mucoadhesive alginate beads of amoxicillin trihydrate: A facile approach for H. pylori eradication, International Journal of Biological Macromolecules, vol.89, pp.622-653, 2016. ,
Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication, Drug Delivery, vol.23, issue.2, pp.405-424, 2016. ,
Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus, International Journal of Pharmaceutics, vol.470, issue.1, pp.28-40, 2014. ,
Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori, Biomaterials, vol.34, issue.18, pp.4466-79, 2013. ,
Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori, Colloids Surfaces B Biointerfaces, vol.164, pp.11-19, 2018. ,
A novel gastroretentive porous microparticle for anti-Helicobacter pylori therapy: preparation, in vitro and in vivo evaluation, International Journal of Pharmaceutics, vol.463, issue.1, pp.10-21, 2014. ,
Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study, Nanomedicine, vol.10, issue.1, 2015. ,
Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm, Journal of Controlled Release, vol.300, pp.52-63, 2019. ,
Helicobacter pylori infection: A brief overview on alternative natural treatments to conventional therapy, Critical Reviews in Microbiology, vol.42, issue.1, 2014. ,
Exploring alternative treatments for Helicobacter pylori infection, World Journal of Gastroenterology, vol.20, issue.6, pp.1450-69, 2014. ,
Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori, International Journal of Pharmaceutics, vol.519, issue.1-2, pp.128-137, 2017. ,
Lipid nanoparticles to counteract gastric infection without affecting gut microbiota, European Journal of Pharmaceutics and Biopharmaceutics, vol.127, 2018. ,
Gastroprotective effects and antimicrobial activity of Lithraea molleoides and isolated compounds against Helicobacter pylori, Journal of Ethnopharmacology, vol.176, pp.469-74, 2015. ,
,
Anti-Helicobacter pylori, gastroprotective, anti-inflammatory, and cytotoxic activities of methanolic extracts of five different populations of Hippocratea celastroides collected in Mexico, Journal of Ethnopharmacology, vol.155, issue.2, pp.1156-63, 2014. ,
Nontraditional therapies to treat Helicobacter pylori infection, Journal of Microbiology, vol.52, issue.4, pp.259-72, 2014. ,
Polysaccharides as Bacterial Antiadhesive Agents and "Smart" Constituents for Improved Drug Delivery Systems Against Helicobacter pylori Infection, Current Pharmaceutical Design, vol.21, issue.33, pp.4888-906, 2015. ,
Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine, Molecular Medicine Reports, vol.12, issue.3, pp.4123-4155, 2015. ,
Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, The Lancet, vol.386, pp.1457-1464, 2015. ,
Progress in vaccine development against Helicobacter pylori, FEMS Immunology & Medical Microbiology, vol.50, issue.2, pp.146-56, 2007. ,
Vaccinating against Helicobacter pylori infection, Nature Reviews Gastroenterology & Hepatology, vol.8, issue.3, pp.133-173, 2011. ,
Antimicrobial properties of chitosan and mode of action: a state of the art review, International Journal of Food Microbiology, vol.144, issue.1, pp.51-63, 2010. ,
Chitosan-based gastrointestinal delivery systems, Journal of Controlled Release, vol.89, issue.2, pp.151-165, 2003. ,
, Evaluation of Mucoadhesive Properties of Chitosan Microspheres Prepared by Different Methods, vol.5, 2004.
,
Modulation of stability and mucoadhesive properties of chitosan microspheres for therapeutic gastric application, International Journal of Pharmaceutics, vol.454, issue.1, pp.116-140, 2013. ,
In vitro evaluation of the mucoadhesive properties of chitosan microspheres, International Journal of Pharmaceutics, vol.166, pp.75-68, 1998. ,
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers, International Journal of Pharmaceutics, vol.78, pp.43-48, 1992. ,
Effects of Chitosan, Pectic Acid, Lysozyme, and Chitinase on the Growth of Several Phytopathogens, Agricultural and Biological Chemistry, vol.53, issue.11, pp.3065-3066, 1989. ,
Recent progresses in bioadhesive microspheres via transmucosal administration, Colloids Surfaces B, vol.140, pp.361-72, 2016. ,
Preparation and evaluation of anti-Helicobacter pylori efficacy of chitosan nanoparticles in vitro and in vivo, Journal of Biomaterials Science, vol.20, issue.11, pp.1587-96, 2009. ,
Effect of gastric environment on Helicobacter pylori adhesion to a mucoadhesive polymer, Acta Biomaterialia, vol.9, issue.2, pp.5208-5223, 2013. ,
,
Bacterial-binding chitosan microspheres for gastric infection treatment and prevention, Acta Biomaterialia, vol.9, issue.12, pp.9370-9378, 2013. ,
Bacteria-targeted biomaterials: Glycan-coated microspheres to bind Helicobacter pylori, Acta Biomaterialia, vol.33, pp.40-50, 2016. ,
Host-bacterial interactions in Helicobacter pylori infection, Gastroenterology, vol.134, issue.1, pp.306-329, 2008. ,
Synthesis of an O-alkynylchitosan and its chemoselective conjugation with a PEG-like amino-azide through click chemistry, Carbohydrate Polymers, vol.87, issue.1, pp.240-249, 2012. ,
Chemical modification of chitosan by phosphorylation: an XPS, FT-IR and SEM study, Journal of Biomaterials Science, vol.16, issue.12, pp.1575-1593, 2005. ,
An infrared investigation in relation with chitin and chitosan characterization, Polymer, vol.42, issue.8, pp.3569-3580, 2001. ,
URL : https://hal.archives-ouvertes.fr/hal-01585443
A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain, Gastroenterology, vol.112, issue.4, pp.1386-1397, 1997. ,
,
Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation, Science, vol.297, issue.5581, pp.573-581, 2002. ,
An invitro adherence assay reveals that Helicobacter pylor exhibits cell lineage-specific tropism in the human gastric epithelium (host-crobil lnteractlons/adheslns/glycoproteins/gastrlc epithelial cell biolgy, Proceedings of the National Academy of Sciences of the USA 90, pp.2035-2039, 1993. ,
Effect of surface chemistry on bacterial adhesion, viability, and morphology, Journal of Biomedical Materials Research A, vol.99, issue.3, pp.344-53, 2011. ,
, Sample preparation and reference materials, Biological evaluation of medical devices, Part, vol.12, pp.10993-11005, 2004.
, Biological evaluation of medical devices Part 5, Tests for in vitro cytotoxicity, pp.10993-10998, 2009.
A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Research, vol.16, issue.3, 1988. ,
Rapid Detection of Helicobacter pylori in Gastric Biopsy Material by Polymerase Chain Reaction, Journal of Clinical Microbiology, vol.30, issue.1, pp.54-58, 1992. ,
Mucoadhesive microparticles for gastroretentive delivery: preparation, biodistribution and targeting evaluation, Marine Drugs, vol.12, issue.12, pp.5764-87, 2014. ,
In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation, Proceedings of the National Academy of Sciences of the USA, vol.111, issue.49, pp.17600-17605, 2014. ,
Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection, Infection and Immunity, vol.69, issue.2, pp.730-736, 2001. ,
Immune Responses of Specific-Pathogen-Free Mice to Chronic Helicobacter pylori (Strain SS1) Infection, Infection and Immunity, vol.66, issue.4, pp.1349-1355, 1998. ,
Boropinic acid, a novel inhibitor of Helicobacter pylori stomach colonization, Journal of Antimicrobial Chemotherapy, vol.64, issue.1, pp.210-211, 2009. ,
Anti-Helicobacter pylori activities of natural isopentenyloxycinnamyl derivatives from Boronia pinnata, Nature Product Communications, vol.7, issue.10, pp.1347-50, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01737658
Design, Synthesis, and Efficacy Testing of Nitroethylene-and 7-Nitrobenzoxadiazol-Based Flavodoxin Inhibitors against Helicobacter pylori Drug-Resistant Clinical Strains and in Helicobacter pylori-Infected Mice, Journal of Medicinal Chemistry, vol.62, issue.13, pp.6102-6115, 2019. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02868148
Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization, Plos One, vol.7, issue.4, p.35072, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01651966
Comparison of three PCR methods for detection of Helicobacter pylori DNA and detection of cagA gene in gastric biopsy specimens, World Journal of Gastroenteroly, vol.10, issue.13, pp.1958-1960, 2004. ,
, Comparative Anatomy and Histology: A Mouse and Human Atlas, pp.155-175, 2012.
Helicobacter felis Eradication Restores Normal Architecture and Inhibits Gastric Cancer Progression in C57BL/6 Mice, Gastroenterology, vol.128, issue.7, pp.1937-1952, 2005. ,
,
Analysis of the toxicity and histopathology induced by the oral administration of Pseudanabaena galeata and Geitlerinema splendidum (cyanobacteria) extracts to mice, Mar Drugs, vol.12, issue.1, pp.508-532, 2014. ,
, Anatomy and Physiology
Synthesis and characterization of biodegradable TPP/genipin co-crosslinked chitosan gel beads, Polymer, vol.44, issue.21, pp.6521-6530, 2003. ,
Mucoadhesive nanoparticulate systems for peptide drug delivery, Advanced Drug Delivery Reviews, vol.47, pp.39-54, 2001. ,
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues, Advanced Drug Delivery Reviews, vol.61, issue.2, pp.158-71, 2009. ,
Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers, Advanced Drug Delivery Reviews, vol.64, issue.6, pp.557-70, 2012. ,
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus, P Natl Acad Sci, vol.104, issue.5, pp.1482-1487, 2007. ,
Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review, Journal of Food and Drug Analysis, vol.23, issue.4, pp.619-629, 2015. ,
Amoxicillin loaded chitosanalginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for H. pylori, Scientific Pharmaceutics, vol.79, issue.3, pp.673-94, 2011. ,
Modified-Chitosan/siRNA Nanoparticles Downregulate Cellular CDX2 Expression and Cross the Gastric Mucus Barrier, Plos One, vol.9, issue.6, 2014. ,
Bioadhesive microspheres: III. An in vivo transit and bioavailability study of drug-loaded alginate and poly(fumaric-co-sebacic anhydride) microspheres, Journal of Controlled Release, vol.48, pp.35-46, 1997. ,
, Chitosan as Antimicrobial Agent: Applications and Mode of Action, vol.4, 2003.
Barrier properties of mucus, Advanced Drug Delivery Reviews, vol.61, issue.2, pp.75-85, 2009. ,
Tetracycline-containing Chitosan Microspheres for Local Treatment of Helicobacter pylori Infection, Cellulose, vol.14, issue.1, pp.3-14, 2006. ,
High-throughput analysis of the impact of antibiotics on the human intestinal microbiota composition, Journal of Microbiological Methods, vol.92, issue.3, pp.387-97, 2013. ,
Impact of treatment of Helicobacter pylori on the normal gastrointestinal microflora, Clinical Microbiology and Infection, vol.6, issue.4, 2000. ,